Vertex Pharma's most recent trend suggests a bearish bias. One trading opportunity on Vertex Pharma is a Bear Call Spread using a strike $65.00 short call and a strike $70.00 long call offers a potential 20.48% return on risk over the next 39 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $65.00 by expiration. The full premium credit of $0.85 would be kept by the premium seller. The risk of $4.15 would be incurred if the stock rose above the $70.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Vertex Pharma is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Vertex Pharma is bearish.
The RSI indicator is below 20 which suggests that the stock is in oversold territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Vertex Pharma
Vertex To Present at Upcoming Investor Conferences
Mon, 11 Nov 2013 21:54:21 GMT
noodls – November 11, 2013 CAMBRIDGE, Mass.–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it will present at the Credit Suisse Healthcare Conference in Scottsdale, AZ on Tuesday, …
Vertex To Present at Upcoming Investor Conferences
Mon, 11 Nov 2013 21:24:00 GMT
Business Wire – Vertex Pharmaceuticals Incorporated announced that it will present at the Credit Suisse Healthcare Conference in Scottsdale, AZ on Tuesday, November 12 at 1:30 p.m. ET.
Will Gilead Sciences Be Able To Continue Its Growth Trajectory?
Mon, 11 Nov 2013 12:59:16 GMT
Seeking Alpha – Shares of Gilead Sciences Inc. ( GILD ) jumped last week when the biotechnology firm reported outstanding third quarter results and also raised its annual forecasts. The revenues of the company were $2.78 …
Chasing Bubbles In The NASDAQ 100 (Part II)
Fri, 08 Nov 2013 08:44:23 GMT
Seeking Alpha – Introduction : I think that bubbles are hidden in the Nasdaq 100. You may want to read why in this article. The proof of a bubble is a divergence between the price and fundamental metrics. This article …
VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report
Thu, 07 Nov 2013 21:23:14 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook